NCT03304457View on ClinicalTrials.gov

Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

March 12, 2018

Study Completion Date

March 25, 2018

Conditions

Schizophrenia

Interventions

DRUG

Olanzapine

Olanzapine 10mg once daily orally for 6 weeks

DRUG

Lurasidone

Lurasidone 80mg once daily orally for 6 weeks

Trial Locations (1)

751019

AIIMS, Bhubaneshwar

All Listed Sponsors

lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT03304457 - Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia | Biotech Hunter | Biotech Hunter